BioVentures Investors raises $87m

BioVentures Investors held a final close on $87 million for its BioVentures Investors IV. The Wellesley-headquartered firm began fundraising in 2015 with a $100 million target. 

Its previous fund raised $51 million in 2007.

The fund will target venture capital opportunities in medical technology enterprises sectors in North America.